A new test for quickly diagnosing urinary tract infections and checking antibiotic resistance
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing
['FUNDING_SBIR_2'] · COBIO DIAGNOSTICS INC. · NIH-10703487
This study is working on a quick test for urinary tract infections (UTIs) that can quickly find out what bacteria are causing the infection and how well they respond to antibiotics, helping doctors choose the best treatment for you faster and more accurately.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COBIO DIAGNOSTICS INC. (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-10703487 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a rapid diagnostic test for urinary tract infections (UTIs) that can quickly identify the presence of bacteria and determine their resistance to antibiotics. By using a method that amplifies bacteriophages, the test aims to provide results faster than traditional methods, which often take longer and may not accurately reflect antibiotic susceptibility. This could help healthcare providers choose the most effective treatment for patients suffering from UTIs, especially in the face of rising antibiotic resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing symptoms of urinary tract infections, particularly those with recurrent infections.
Not a fit: Patients with UTIs caused by non-bacterial pathogens or those who do not have urinary tract infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and timely treatment options for patients with urinary tract infections.
How similar studies have performed: Previous research has shown promise in using rapid diagnostic tests for infections, indicating that this approach could be effective.
Where this research is happening
Aurora, UNITED STATES
- COBIO DIAGNOSTICS INC. — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: COX, CHRISTOPHER R — COBIO DIAGNOSTICS INC.
- Study coordinator: COX, CHRISTOPHER R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.